This company has been marked as potentially delisted and may not be actively trading. BiondVax Pharmaceuticals (BVXV) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock BVXV Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period BiondVax Pharmaceuticals (NASDAQ: BVXV)May 8, 2024 | fool.comSCNI Scinai Immunotherapeutics Ltd.March 23, 2024 | seekingalpha.comScinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023October 4, 2023 | finance.yahoo.comScinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct OfferingSeptember 19, 2023 | finance.yahoo.comScinai Immunotherapeutics Announces $1.33 Million Registered Direct OfferingSeptember 15, 2023 | finance.yahoo.comScinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical ResultsSeptember 13, 2023 | finance.yahoo.comScinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in BostonSeptember 11, 2023 | finance.yahoo.comBiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd. to Reflect New Focus on Development of Novel Inflammation and Immunology (I&I) Biological TherapeuticsSeptember 6, 2023 | financialpost.comFBiondVax Pharmaceuticals Ltd.: BiondVax Reports Second Quarter Financial Results and Provides Business UpdateAugust 11, 2023 | finanznachrichten.deBiondVax Reports Second Quarter Financial Results and Provides Business UpdateAugust 11, 2023 | finance.yahoo.comBiondVax Pharmaceuticals Ltd.: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing RulesAugust 2, 2023 | finanznachrichten.deNasdaq Grants BiondVax Extension to Regain Compliance with Listing RulesAugust 1, 2023 | finance.yahoo.comBiondVax (NASDAQ: BVXV) Leveraging NanoAb Pipeline to Target Large MarketsJuly 28, 2023 | theglobeandmail.comIBN Announces Latest Episode of The Bell2Bell Podcast featuring Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd.July 11, 2023 | finance.yahoo.comBVXV - BiondVax Pharmaceuticals Ltd.July 6, 2023 | finance.yahoo.comBiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasisJune 5, 2023 | finance.yahoo.comBVXV: Developing anti-IL-17 NanoAbMay 30, 2023 | finance.yahoo.comBiondVax Pharmaceuticals Ltd.: BiondVax Announces First Quarter 2023 Financial Results and Provides Business UpdateMay 15, 2023 | finanznachrichten.deBiondvax Pharmaceuticals GAAP EPS of $0.00 beats by $0.73May 15, 2023 | msn.comBiondVax Announces First Quarter 2023 Financial Results and Provides Business UpdateMay 15, 2023 | finance.yahoo.comBiondVax Pharmaceuticals (NASDAQ: BVXV) Leads Biotechnology Frontier with Experienced Leadership TeamApril 20, 2023 | theglobeandmail.comBiondVax Pharmaceuticals Ltd.: BiondVax Files FY 2022 Financial Statements and Annual Report on Form 10-K and Provides Business UpdateApril 18, 2023 | finanznachrichten.deBioMedNewsBreaks - BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) Lead NanoAb Candidate Holds Significant Advantages to Existing TherapiesApril 4, 2023 | marketwatch.comBioMedNewsBreaks - BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) NanoAb Holds Potential to Combat New COVID-19 VariantsMarch 26, 2023 | marketwatch.comBiondVax to Present at BIO-Europe SpringMarch 16, 2023 | finance.yahoo.comIBN Highlights 'Test. Optimize. Scale.' Episode Featuring BiondVax Pharmaceuticals Ltd. CEO Amir ReichmanMarch 6, 2023 | finance.yahoo.comIBN Announces ‘Test. Optimize. Scale.’ Interview with BiondVax Pharmaceuticals Ltd. CEO Amir Reichman Discussing De-Risked Development Pipeline and Strategic Partnerships with Premier European Research InstitutesMarch 3, 2023 | finance.yahoo.comBiondVax Presenting at BIO CEO & Investor ConferenceFebruary 2, 2023 | finance.yahoo.comBioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) NanoAb May Serve as Therapeutic and Prophylactic as Shown in Preclinical StudyJanuary 25, 2023 | benzinga.comBiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Developing Innovative Inhaled NanoAb Therapeutics for Multiple Indications, Including COVID-19January 25, 2023 | benzinga.comBiondVax Pharma: In Vivo Data Shows NanoAb Virtually Prevents COVID-19 In HamstersJanuary 23, 2023 | markets.businessinsider.comBiondVax Touts Additional Preclinical Data From Inhaled COVID-19 Treatment CandidateJanuary 23, 2023 | finance.yahoo.comBiondVax's Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo StudyJanuary 23, 2023 | it.tmcnet.comBiondVax’s Innovative Inhaled Anti-SARS-CoV-2 NanoAb Virtually Prevented Illness When Administered Prophylactically in Preclinical In Vivo StudyJanuary 23, 2023 | finance.yahoo.comBioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.'s (NASDAQ: BVXV) NanoAb Pipeline Targeting Large Underserved Medical NeedsJanuary 15, 2023 | benzinga.comBiondVax Pharmaceuticals (Nasdaq:BVXV) HeadlineTrading was temporarily halted for "BVXV" at 09:01 AM with a stated reason of "LULD pause."...January 6, 2023 | marketbeat.comBiondVax's Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo StudyJanuary 6, 2023 | benzinga.comBiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo StudyJanuary 6, 2023 | finance.yahoo.comBiondVax to Present at Biotech Showcase 2023January 5, 2023 | finance.yahoo.comBiondVax CEO Issues Letter to ShareholdersDecember 30, 2022 | finance.yahoo.comAegis Capital Corp. Acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)December 21, 2022 | finance.yahoo.comWhy Biondvax Pharmaceuticals Stock Is Getting Obliterated During Friday's Trading SessionDecember 16, 2022 | msn.comBiondVax Pharmaceuticals (Nasdaq:BVXV) HeadlineTrading was temporarily halted for "BVXV" at 09:12 AM with a stated reason of "LULD pause."...December 16, 2022 | marketbeat.comBiondVax Pharmaceuticals Ltd.: BiondVax Regains Nasdaq ComplianceDecember 13, 2022 | finanznachrichten.deIBN Announces Latest Episode of The Stock2Me Podcast featuring Amir Reichman, CEO of BiondVax Pharmaceuticals Ltd.December 13, 2022 | finance.yahoo.comBiondVax Regains Nasdaq ComplianceDecember 12, 2022 | finance.yahoo.comBVXV: Positive Preclinical Results for Inhaled COVID-19 NanoAb…December 8, 2022 | finance.yahoo.comProfessor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory BoardDecember 6, 2022 | finance.yahoo.comIBN (InvestorBrandNetwork) Coverage Initiated for BiondVax Pharmaceuticals Ltd.December 6, 2022 | finance.yahoo.comBiondVax announces Third Quarter 2022 Financial Results and Provides Business UpdateNovember 30, 2022 | finance.yahoo.com Get BiondVax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXV and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BVXV Media Mentions By Week BVXV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BVXV News Sentiment▼0.420.92▲Average Medical News Sentiment BVXV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BVXV Articles This Week▼00▲BVXV Articles Average Week Get the Latest News and Ratings for BVXV and Related Stocks Enter your email address to receive the latest news and analysts' ratings for BiondVax Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ADIL News Today SXTPW News Today DRTSW News Today BCTXW News Today ENGNW News Today FBIOP News Today GOVXW News Today JSPRW News Today NAMSW News Today NTRBW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BVXV) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BiondVax Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share BiondVax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
